BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24055032)

  • 1. Clinical significance of proliferation, apoptosis and senescence of nasopharyngeal cells by the simultaneously blocking EGF, IGF-1 receptors and Bcl-xl genes.
    Dai G; Peng T; Zhou X; Zhu J; Kong Z; Ma L; Xiong Z; Yuan Y
    Biochem Biophys Res Commun; 2013 Nov; 440(4):479-84. PubMed ID: 24055032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual silencing of type 1 insulin-like growth factor and epidermal growth factor receptors to induce apoptosis of nasopharyngeal cancer cells.
    Yuan YL; Zhou XH; Song J; Qiu XP; Li J; Ye LF
    J Laryngol Otol; 2008 Sep; 122(9):952-60. PubMed ID: 17908353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA interference by expression of short hairpin RNAs suppresses bcl-xL gene expression in nasopharyngeal carcinoma cells.
    Liu F; He CW; Zhang YF; Zhou KY
    Acta Pharmacol Sin; 2005 Feb; 26(2):228-34. PubMed ID: 15663904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducing apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z by bcl-xL short hairpin RNA.
    He CW; Liu F; Zhang YF; Liang T; Zhou KY
    Ai Zheng; 2005 Jun; 24(6):646-52. PubMed ID: 15946471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual silencing of epidermal growth factor and insulin-like growth factor 1 receptors significantly limits growth of nasopharyngeal carcinoma in nude mice.
    Zhou X; Yuan Y; Song J; Chen W; Li J; Ye L; Meng X; Xia D
    J Laryngol Otol; 2009 Feb; 123(2):208-22. PubMed ID: 18452630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Knockdown of bcl-xL expression with RNA interference induces nasopharyngeal carcinoma cells apoptosis].
    Li JX; Zhou KY; Cai KR; Liang T; Tang XD; Zhang YF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 May; 40(5):347-51. PubMed ID: 16229175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Suppression of insulin-like growth factor-1 receptor by RNA interference inhibits cell growth in vitro and induces chemosensitization of HO8910PM cell to cisplatin].
    Gao H; Shi J; Ge SF; DI W
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):45-9. PubMed ID: 18366933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells.
    Riedemann J; Sohail M; Macaulay VM
    Biochem Biophys Res Commun; 2007 Apr; 355(3):700-6. PubMed ID: 17320820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGF-dependent induction of BCL-xL and p21CIP1/WAF1 is highly variable in HNSCC cells--implications for EGFR-targeted therapies.
    Rüddel J; Wennekes VE; Meissner W; Werner JA; Mandic R
    Anticancer Res; 2010 Nov; 30(11):4579-85. PubMed ID: 21115909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGF receptor signaling inhibits keratinocyte apoptosis: evidence for mediation by Bcl-XL.
    Stoll SW; Benedict M; Mitra R; Hiniker A; Elder JT; Nuñez G
    Oncogene; 1998 Mar; 16(11):1493-9. PubMed ID: 9580112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of the expression of B‑cell lymphoma-extra large by RNA interference induces apoptosis and enhances the radiosensitivity of non‑small cell lung cancer cells.
    Yang C; Huang W; Yan L; Wang Y; Wang W; Liu D; Zuo X
    Mol Med Rep; 2015 Jul; 12(1):449-55. PubMed ID: 25683634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of short hairpin RNA of Bcl-xL gene on biological behaviors of HepG-2 cells.
    Mengxi D; Hong Y; Nan W; Shijun L; Yanmei J
    Med Oncol; 2012 Jun; 29(2):1000-4. PubMed ID: 21533603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation.
    Zou M; Xia S; Zhuang L; Han N; Chu Q; Chao T; Peng P; Chen Y; Gui Q; Yu S
    Int J Oncol; 2013 Jun; 42(6):2094-102. PubMed ID: 23588221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apoptotic effect of bcl-XL antisense oligodeoxynucleotide mediated by lipofectin on cell strain CNE-2Z].
    He GR; Zhou KY; Cai KR; Liang T; He CW; Zhang YF
    Ai Zheng; 2003 Jan; 22(1):11-5. PubMed ID: 12561428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bcl-XL antisense oligodeoxynucleotide sensitizes human esophageal cancer cell line to 5-fluorouracil].
    Zhang L; Wen HT; Wang LX; Zhang L; Zhang YH
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):173-7. PubMed ID: 16875599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of short hairpin RNA targeting epidermal growth factor receptor in growth and sensitivity to drugs of human lung adenocarcinoma cells.
    Bai L; Zhu R; Chen Z; Gao L; Zhang X; Wang X; Bai C
    Biochem Pharmacol; 2006 Apr; 71(8):1265-71. PubMed ID: 16442503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressing the growth of rectal cancer xenografts derived from patient tumors by an adenovector expressing small hairpin RNA targeting Bcl-XL.
    Zhu H; Zhou W; Hu J; Huang Z; Lao W; Huang X; He C
    J Gene Med; 2012 Dec; 14(12):761-8. PubMed ID: 23169477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity.
    Tortora G; Caputo R; Damiano V; Caputo R; Troiani T; Veneziani BM; De Placido S; Bianco AR; Zangemeister-Wittke U; Ciardiello F
    Clin Cancer Res; 2003 Feb; 9(2):866-71. PubMed ID: 12576461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.
    Yamanaka K; Rocchi P; Miyake H; Fazli L; So A; Zangemeister-Wittke U; Gleave ME
    BJU Int; 2006 Jun; 97(6):1300-8. PubMed ID: 16686729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.